NICE has been collaborating with NHS England on the Chemotherapy Dose Standardisation initiative which has been developed by the Medicines Optimisation and Chemotherapy Clinical Reference Groups (CRGs ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

At present, most chemotherapy drug treatments against cancer are delivered by an intravenous drip over several hours on a hospital ward. Patients normally have to make daily trips for a week at a ...

Unlike normal chemotherapy treatments that are given through an IV and circulated through the bloodstream, this treatment is performed at the time of surgery for cancer and the chemotherapy is heated ...

Liver cancer treatment has advanced from intravenous delivery of chemotherapy drugs, which affects not only the tumor and liver but also organs throughout the body (red, left), to intra-arterial ...

Enriqueta Felip, MD, PhD, discusses the phase 3 3475A-D77 study of subcutaneous pembrolizumab plus chemotherapy in metastatic non–small cell lung cancer.

The therapy also reduced the amount of time patients spend receiving chemotherapy treatment by 49.7% compared with IV Keytruda. At the same time, secondary objectives comparing objective response rate ...

Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and ...

For Mike, a procedure to implant a port to deliver medication marked the beginning of intravenous chemotherapy. But before chemo, there was radiation — 30 rounds of targeted therapy to shrink ...

Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy and safety profile with IV pembrolizumab.